Madras motor neuron disease

Madras motor neuron disease (MMND), also known as Madras-type motor neuron disease, is a rare neurodegenerative disorder first described in patients from the city of Chennai (formerly Madras) in southern India. It is characterized by progressive lower motor neuron weakness and wasting, predominantly affecting the limbs, combined with sensorineural hearing loss and cranial nerve involvement, particularly affecting the facial nerve and bulbar muscles. The disease typically presents in young individuals, often in the second or third decade of life, distinguishing it from classical amyotrophic lateral sclerosis (ALS). Key clinical features include asymmetric limb weakness and atrophy, bilateral sensorineural deafness, and lower cranial nerve palsies leading to facial weakness, tongue atrophy, and difficulty swallowing. Upper motor neuron signs are generally absent or minimal, which differentiates MMND from typical ALS. The disease tends to follow a slowly progressive or sometimes relatively benign course compared to classical motor neuron diseases, with patients surviving for many years after onset. The exact cause of Madras motor neuron disease remains unknown. Most reported cases have been sporadic, though occasional familial clustering has been noted, raising the possibility of a genetic predisposition potentially interacting with environmental factors. The disease has been predominantly reported in individuals from southern India, particularly from lower socioeconomic backgrounds, though rare cases have been described in other populations. Diagnosis is based on clinical features, electromyography showing denervation patterns consistent with lower motor neuron disease, audiometry confirming sensorineural hearing loss, and neuroimaging to exclude other causes. There is currently no specific or curative treatment for MMND. Management is supportive and symptomatic, including hearing aids for deafness, physical therapy to maintain mobility, speech therapy for bulbar dysfunction, and nutritional support when swallowing is impaired. Research into the underlying pathogenesis continues, but the rarity of the condition limits large-scale clinical studies.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Madras motor neuron disease